Rash grade (n) Immunotherapy class, n Immunotherapy class, n Immunotherapy class, n Immunotherapy class, n Rash treatment, n Rash treatment, n Rash treatment, n Rash treatment, n Impact on immunotherapy, n Impact on immunotherapy, n Impact on immunotherapy, n Rash improved, n, yes/no
Anti–PD-1 Anti–PD-L1 Anti–CTLA-4 Combined anti–PD-1 and anti–CTLA-4 1 2 3 4 None Temporarily interrupted Permanently discontinued
1 (27) 20 4 2 1 17 5 4 1 15 4 8 26/1
2 (12) 7 2 0 3 5 2 2 3 1 3 8 11/1
3 (3) 2 0 0 1 0 0 1 2 0 0 3 3/0
4 (0) 0 0 0 0 0 0 0 0 0 0 0 0/0
Total (42) 29 6 2 5 22 7 7 6 16 7 19 20/2